Abstract
It is not always practical for persons, whose occupation or activities mandate the use of irritants or allergens, to avoid their use. In order to reduce the risk of developing irritant contact dermatitis (ICD) and allergic contact dermatitis (ACD) in industry, prophylactic measures are indicated. Application of moisturizers as well as barrier creams (BCs) before or during work and wearing appropriate gloves and clothing may be protective. Oral and, to a lesser extent, topical corticoids have demonstrated significant efficacy in the treatment of ACD. Additional therapies include UVB/UVA treatment, other immunosuppressives, and Grenz ray.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Aalto-Korte K, Turpeinen M (1995) Pharmacokinetics of topical hydrocortisone at plasma level after applications once or twice daily in patients with widespread dermatitis. Br J Dermatol 133:259–263
Altura BM (1966) Role of glucocorticoids in local regulation of blood flow. Am J Physiol 211:1393–1397
Amin S, Maibach HI (1997) Immunologic contact urticaria definition. In: Contact urticaria syndrome. Amin S, Lahti A, Maibach HI (eds), CRC Press, Boca Raton, pp 11–26
Ballard PL, Baxter JD, Higgins SJ, Rousseau GC, Tomkins GM (1974) General presence of glucocorticoid receptors in mammalian tissues. Endocrin 94:998–1002
Barry BW, Woodford R (1977) Vasoconstrictor activities and bioavailabilities of seven proprietary corticosteroid creams assessed using a non-occluded multiple dosage regimen: clinical considerations. Br J Dermatol 97:555–560
Birmingham D (1969) Prevention of occupational skin disease. Cutis 5:153–156
Blackwell GJ, Carnuccio R, DiRosa M, Flower RJ, Parente L, Pérsico P (1980) Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature 287:147–149
Blichmann CW, Serup J, Winther A (1989) Effects of single application of a moisturizer: evaporation of emulsion water, skin surface temperature, electrical conductance, electrical capacitance, and skin surface (emulsion) lipids. Acta Derm Venereol 69:327–330
Bode HH (1980) Dwarfism following long-term topical corticosteroid therapy. J Am Med Assoc 244:813–814
Boman A, Wahlberg JE, Johansson G (1982) A method for the study of the effect of barrier creams and protective gloves on the percutaneous absorption of solvents. Dermatológica 164:157–160
Carr RD, Tarnowski WM (1968) Percutaneous absorption of corticosteroids: adrenocortical suppression with total body inunction. Acta Derm Venereol 48:417–428
Christensen OB (1994) UV-light treatment of hand eczema. In: Menné T, Maibach HI (eds) Hand eczema. CRC Press, Boca Raton, pp 293–301
Cronin E, Stoughton RB (1962) Percutaneous absorption: regional variations and the effect of hydration and epidermal stripping. Br J Dermatol 74:265–272
Davidson CL (1994) Occupational contact dermatitis of the upper extremity. Occup Med 9:59–74
Du Vivier A, Stoughton RB (1976) Acute tolerance to effects of topical glucocorticoids. Br J Dermatol 94[Suppl 121:25–32
Du Vivier A, Phillips H, Hehir M (1982) Applications of glucocorticosteroids: the effects of twice-daily vs once-every-other-day applications on mouse epidermal cell DNA synthesis. Arch Dermatol 118:305–308
Epstein EH, Bonifas JM (1982) Glucocorticoid receptors of the human epidermis. J Invest Dermatol 78:144–146
Estlander T, Jolanki R, Kanerva L (1994) Protective gloves. In: Menné T, Maibach HI (eds) Hand eczema. CRC Press, Boca Raton, pp 311–321
Estlander T, Jolanki R, Kanerva L (1996) Rubber glove dermatitis: a significant occupational hazard-prevention. In: Eisner P, Lachapelle JM, Wahlberg JE, Maibach HI (eds) Prevention of contact dermatitis. (Curr Probl Dermatol) Karger, Basel, pp 170–176
Feldmann RJ, Maibach HI (1965) Penetration of 14C-hydrocortisone through normal human skin: the effect of stripping and occlusion. Arch Dermatol 91:661–666
Feldmann RJ, Maibach HI (1966) Percutaneous penetration of hydrocortisone in man. II. Effect of certain bases and pretreatments. Arch Dermatol 94:649–651
Feldmann RJ, Maibach HI (1967) Regional variation in percutaneous penetration of 14C Cortisol in man. J Invest Dermatol 48:181–183
Feldmann RJ, Maibach HI (1968) Percutaneous penetration of steroids in man. J Invest Dermatol 52:89–94
Feldmann RJ, Maibach HI (1974) Percutaneous penetration of hydrocortisone with urea. Arch Dermatol 109:58–59
Fredrickson T, Lassus A, Bleeker J (1980) Treatment of psoriasis and atopic dermatitis with halcinonide cream applied once, two-three times daily. Br J Dermatol 102: 575–577
Frosch PJ, Kurte A (1994) Efficacy of skin barrier creams. (IV). The repetitive irritation test (RIT) with a set of 4 standard irritants. Contact Dermatitis 31:161–168
Frosch PJ, Kurte A, Pilz B (1993) Biophysical techniques for the evaluation of skin protective creams. In: Frosch PJ, Kligman AM (eds) Noninvasive methods for the quantification of skin functions. Springer, Berlin Heidelberg New York, pp 214–222
Frosch PJ, Kurte A, Pilz B (1993) Efficacy of skin barrier creams. (III). The repetitive irritation test (RIT) in humans. Contact Dermatitis 29:113–118
Frosch PJ, Schulze-Dirks A, Hoffmann M, Axthelm I (1993) Efficacy of skin barrier creams. (II). Ineffectiveness of a popular “skin protector” against various irritants in the repetitive irritation test in the guinea pig. Contact Dermatitis 2974–77
Frosch PJ, Schulze-Dirks A, Hoffmann M, Axthelm I, Kurte A (1993) Efficacy of skin barrier creams. (I). The repetitive irritation test (RIT) in the guinea pig. Contact Dermatitis 28:94–100
Fullerton A, Menne T (1995) In vitro and in vivo evaluation of the effect of barrier gels in nickel contact allergy. Contact Dermatitis 32:100–106
Funk JO, Maibach HI (1994) Horizons in pharmacologic intervention in allergic contact dermatitis. J Am Acad Dermatol 31:999–1014
Gammal CE, Pagnoni A, Kligman AM, Gammal SE (1996) A model to assess the efficacy of moisturizers — the quantification of soap-induced xerosis by image analysis of adhesive-coated discs (D-Squames). Clin Exp Dermatol 21:338–343
Ginsburg J, Duff RS (1958) Influence of intra-arterial hydrocortisone on adrenergic responses in the hand. BMJ 2:424–428
Goh CL (1991) Cutting oil dermatitis on guinea pig skin. (I). Cutting oil dermatitis and barrier cream. Contact Dermatitis 24:16–21
Goh CL (1991) Cutting oil dermatitis on guinea pig skin. (II). Emollient creams and cutting oil dermatitis. Contact Dermatitis 24:81–85
Goh CL, Gan SL (1994) Efficacies of a barrier cream and an afterwork emollient cream against cutting fluid dermatitis in metalworkers: a prospective study. Contact Dermatitis 31:176–180
Grevelink SA, Murrell DF, Olsen EA (1992) Effectiveness of various barrier preparations in preventing and/or ameliorating experimentally produced Toxicodendron dermatitis. J Am Acad Dermatol 27:182–188
Grunewald AM, Lorenz J, Gloor M, Gehring W, Kleesz P (1996) Lipophilic irritants: protective value of urea- and of glycerol-containing oil in water emulsions. Dermatosen 44:81–86
Halkier-Sorensen L, Thestrup-Pedersen K (1993) The efficacy of a moisturizer (Locobase) among cleaners and kitchen assistants during everyday exposure to water and detergents. Contact Dermatitis 29:266–271
Hannuksela A (1996) Moisturizers in the prevention of contact dermatitis. In: Eisner P, Lachapeíle JM, Wahlberg JE, Maibach HI (eds) Prevention of contact dermatitis. (Curr Probl Dermatol) Karger, Basel, pp 214–220
Hannuksela A, Kinnunen T (1992) Moisturizers prevent irritant dermatitis Acta Derm Venereol 72:42–44
Haynes RC, Muraud F (1985) Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of adrenocortical steroid biosynthesis. In: Gilman AG, Goodman LS, Rail TW, Murad F (eds) The pharmacological basics of therapeutics. Macmillan Publishing company, New York, pp 1459–1489
Held E, Sveinsdóttir S, Agner T (1999) Effect of long-term use of moisturizer on skin hydration, barrier function and susceptibility to irritants. Acta Derm Venereol 79:49–51
Hirata F, Schiffmann E, Venkatasubamanian K, Salomon D, Axelrod J (1980) A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids. Proc Natl Acad Sei USA 77:2533–2536
Juhlin L, Michaelsson G (1969) Cutaneous vascular reactions to prostaglandins in healthy subjects and in patients with urticaria and atopic dermatitis. Acta Derm Venereol 49: 251–261
Lachapelle JM (1996) Efficacy of protective creams and/or gels. In: Eisner P, Lachapelle JM, Wahlberg JE, Maibach HI (eds) Prevention of contact dermatitis. (Curr Probl Dermatol) Karger, Basel, pp 182–192
Lachapelle JM, Nouaigui H, Marot L (1990) Experimental study of the effects of a new protective cream against skin irritation provoked by the organic solvents n-hexane, trichlorethylene and toluene. Dermatosen 38:19–23
Lagos BR, Maibach HI (1998) Frequency of application of topical corticosteroids: an overview. Br J Dermatol 139: 763–766
Lavker R, Scheckter N (1985) Cutaneous mast cell depletion results from topical corticosteroid usgae. J Immunol 135:2368–2373
Lindelöf B (1994) X-ray treatment of hand eczema. In: Menné T, Maibach HI (eds) Hand eczema. CRC Press, Boca Raton, PP 303–309
Loden M (1995) Biophysical properties of dry atopic and normal skin with special reference to effects of skin care products. Acta Derm Venereol Suppl (Stockh) 192:1–48
Loden M (1996) Urea-containing moisturizers influence barrier properties of normal skin. Arch Dermatol Res 288:103–107
Loden M (1997) Barrier recovery and influence of irritant stimuli in skin treated with a moisturizing cream. Contact Dermatitis 36:256–260
Loden M, Lindberg M (1991) The influence of a single application of different moisturizers on the skin capacitance. Acta Derm Venereol 71:79–82
Loden M, Maibach HI (1999) Skin moisturizers: development and clinical use. CRC Press, Boca Raton (in press)
Maibach HI, Körting HC (1993) Topical glucocorticoids with increased benefit/risk ratio. Karger, Basel
Maibach HI, Surber C (1992) Topical corticorsteroids. Karger, Basel
Malkinson FD, Ferguson EH (1955) Percutaneous absorption of hydrocortisone-1-C14 in two human subjects. J Invest Dermatol 25:281–283
Marks JG Jr, Fowler JF Jr, Sherertz EF, Rietschel RL (1995) Prevention of poison ivy and poison oak allergic contact dermatitis by quaternium-18 bentonite. J Am Acad Dermatol 33:212–216
Mathias CGT (1990) Prevention of occupational contact dermatitis. J Am Acad Dermatol 23:742–748
McClain DC, Storrs F (1992) Protective effect of both a barrier cream and a polyethylene laminate glove against epoxy resin, glyceryl monothioglycolate, frullania, and tansy. Am J Contact Dermat 13:201–205
Mckenzie AW, Stoughton RB (1962) Method for comparing percutaneous absorption of steroids. Arch Dermatol 86:603–610
Mellström GA, Wahlberg JM, Maibach HI (1994) Protective gloves for occupational use. CRC Press, Boca Raton
Mellström GA, Johansson S, Nyhammar E (1996) Barrier effect of gloves against cytostatic drugs. In: Eisner P, Lachapelle JM, Wahlberg JE, Maibach HI (eds) Prevention of contact dermatitis. (Curr Probl Dermatol) Karger, Basel, pp 163–169
Menné T, Maibach HI (1999) Hand eczema, 2nd edn, CRC Press, Boca Raton
Miller JA, Munro DD (1980) Topical corticosteroids: clinical pharmacology and therapeutic use. Drugs 19:119–134
Munro DD (1976) The effect of percutaneously absorbed steroids on hypothalamic-pituitary-adrenal function after intensive use in patients. Br J Dermatol 94[Suppl 12]:67–76
Olivarius FDF, Hansen AB, Karlsmark T, Wulf HC (1996) Water protective effect of barrier creams and moisturizing creams: a new in vivo test method. Contact Dermatitis 35:219–225
Orchard S (1984) Barrier creams. Dermatol Clin 2:619–629
Packham CL (1994) Evaluation of barrier creams: an in vitro technique on human skin (letter). Acta Derm Venereol 74:405
Parrillo JE, Fauci AS (1979) Mechanisms of glucocorticoid action on immune processes. Ann Rev Pharmacol Toxicol 19:179–201
Ramsing DW, Agner T (1995) Efficacy of topical corticosteroids on irritant skin reactions. Contact Dermatitis 32:293–297
Reiner R, Roßmann K, Hooidonk CV, Ceulen BI, Bock J (1982) Ointments for the protection against organophos-phate poisoning. Arzneimittelforschung 32:630–633
Schlâter-Wigger W, Eisner P (1996) Efficacy of 4 commercially available protective creams in the repetitive irritation test (RIT), Contact Dermatitis 34:278–283
Scoggins RB, Kliman B (1965) Relative potency of percutaneously absorbed corticosteroids in the suppression of pituitary-adrenal function. J Invest Dermatol 45:347–355
Serup J (1992) A double-blind comparison of two creams containing urea as the active ingredient, Assessment of efficacy and side-effects by non-invasive techniques and a clinical scoring scheme. Acta Derm Venereol Suppl (Stockh) 177:34–43
Serup J (1992) A three-hour test for rapid comparison of effects of moisturizers and active constituents (urea), measurement of hydration, scaling and skin surface lipid-ization by noninvasive techniques. Acta Derm Venereol Suppl (Stockh) 177:29–33
Serup J, Winther A, Blichmann CW (1989) Effects of repeated application of a moisturizer. Acta Derm Venereol 69:457–459
Singh G, Singh P (1986) Tachyphylaxis to topical steroid measured by histamine-induced wheal response. Int J Dermatol 25:324–326
Solomon LM, Wentzel HE, Greenberg MS (1965) Studies in the mechanism of steroid vasoconstriction. J Invest Dermatol 44:129–131
Stoughton RB (1972) Bioassay systems for topically applied glucocorticoids. Arch Dermatol 106:825–827
Sulzberger MB, Witten VH (1957) The effect of topically applied compound F in selected dermatoses. J Invest Dermatol 19:101–102
Swanbeck G (1992) Urea in the treatment of dry skin. Acta Derm Venereol Suppl (Stockh) 177:7–8
Thompson J, van Fürth R (1970) The effect of glucocortic-oidsteroids on the kinetics of mononuclear phagocytes. J Exp Med 131:429–442
Treffel P, Gabard B (1996) Bioengineering measurements of barrier creams efficacy against toluene and NaOH in an in vivo single irritation test. Skin Res Technol 2:83–87
Treffel P, Gabard B, Juch R (1994) Evaluation of barrier creams: an in vitro technique on human skin. Acta Derm Venereol 74:7–11
Van der Valk PGM, Maibach HI (1996) The irritant contact dermatitis syndrome. CRC Press, Boca Raton
Vermeer BJ, Heremans GFP (1974) A case of growth retardation and Cushing’s syndrome due to excessive application of betamethasone-17-valerate ointment. Dermatológica 149:299–304
Vernon-Roberts B (1969) The effects of steroid hormones on macrophage activity. Int Rev Cytol 25:131–159
Vickers CFH (1963) Existence of reservoir in the stratum corneum. Arch Dermatol 88:20–23
Wertz PW, Downing DT (1990) Metabolism of topically applied fatty acid methyl esters in BALB/C mouse epidermis. J Dermatol Sei 1:33–37
Weston WL, Sams WM, Morris HG (1980) Morning plasma Cortisol levels in infants treated with topical fluorinated glucocorticosteroids. Paediatrics 65:103–106
Wigger-Alberti W, Eisner P (1998) Do barrier creams and gloves prevent or provoke contact dermatitis? Am J Contact Dermat 9:100–106
Wigger-Alberti W, Maraffio B, Wernli M, Eisner P (1997) Self-application of a protective cream. Pitfalls of occupational skin protection. Arch Dermatol 133:861–864
Wohlrab W (1990) Effect of urea on penetration kinetics of vitamin A acid in human skin. Z Hautkr 65:803–805
Wormser U, Brodsky B, Green BS, Arad-Yellin R, Nyska A (1997) Protective effect of povidone-iodine ointment against skin lesions induced by sulphur and nitrogen mustards and by non-mustard vesicants. Arch Toxicol 71:165–170
Zhai H, Maibach HI (1996) Effect of barrier creams: human skin in vivo. Contact Dermatitis 35:92–96
Zhai H, Maibach HI (1996) Percutaneous penetration (Dermatopharmacokinetics) in evaluating barrier creams. In: Eisner P, Lachapelle JM, Wahlberg JE, Maibach HI (eds) Prevention of contact dermatitis. (Curr Probl Dermatol) Karger, Basel, pp 193–205
Zhai H, Maibach HI (1998) Moisturizers in preventing irritant contact dermatitis: an overview. Contact Dermatitis 38:241–244
Zhai H, Willard P, Maibach HI (1998) Evaluating skin-protective materials against contact irritants and allergens: an in vivo screening human model. Contact Dermatitis 38:155–158
Zhai H, Buddrus DJ, Schulz AA, Wester RC, Hartway T, Serranzana S, Maibach HI (1999) In vitro percutaneous absorption of sodium lauryl sulfate (SLS) in human skin decreased by quaternium-18 bentonite gels. In Vitro Mol Toxicol (in press)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Zhai, H., Anigbogu, A., Maibach, H.I. (2000). Treatment of Irritant and Allergic Contact Dermatitis. In: Kanerva, L., Wahlberg, J.E., Elsner, P., Maibach, H.I. (eds) Handbook of Occupational Dermatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-07677-4_51
Download citation
DOI: https://doi.org/10.1007/978-3-662-07677-4_51
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-07679-8
Online ISBN: 978-3-662-07677-4
eBook Packages: Springer Book Archive